세계의 H1N1 백신 시장 리포트(2023년)

“H1N1 Vaccine Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on h1n1 vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for h1n1 vaccine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The h1n1 vaccine market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product Type: Inactivated Vaccine; Live Attenuated Vaccine

• 2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination

• 3) By End Users: Hospitals; Clinics; Research and Diagnostic Laboratories; Other End Users

• Companies Mentioned: Sanofi; Novartis AG; GlaxoSmithKline plc; CSL Limited; AstraZeneca

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the H1N1 vaccine market are: Sanofi, Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca, Zydus Cadila, Merck and Co.Inc., NovavaxInc., Baxter, Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation., Seqirus, and Cipla Inc.

The global H1N1 vaccine market is expected to grow from $2.94 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The H1N1 vaccine market is expected to grow to $4.04 billion in 2027 at a CAGR of 6.5%.

The H1N1 vaccines market consists of sales of TIV (flu shot (injection) and LAIV (nasal spray (mist) of live attenuated influenza vaccine). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

H1N1 vaccines are administered to people six months of age and older to immunize them against influenza diseases brought on by the H1N1 2009 virus. These are used to prevent humans from Influenza virus infection by injecting a small dose of the virus inside the body to build immunity against the virus.

North America was the largest region in the H1N1 vaccine market in 2022. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main product types of H1N1 vaccine are inactivated vaccine, and live attenuated vaccine. The inactivated vaccine market consists of sales of H1N1 vaccine products that are used to prevent disease caused by the influenza H1N1 virus. Inactivated vaccine is a synthetic vaccine with protective immunising action that contains hemagglutinin (HA) antigens generated from four inactivated influenza viruses, including two different influenza type. A strains and two different influenza type B strains. The various routes of administration include intradermal vaccination, intramuscular vaccination, and subcutaneous vaccination which are used by various end users such as hospitals, clinics, research and diagnostic laboratories, and others.

Increasing expenditure for research and development activities in the field of immunology and vaccine is expected to propel the growth of the H1N1 vaccine market going forward. Immunology and vaccine are used to prevent infections and help in producing antibodies to fight infections. Immunology is a crucial area of research in the medical and biological sciences that focuses on understanding the immune system. The H1N1 vaccine is a preparation used to boost antibody production, which provides immunity against a variety of diseases. For instance, according to an article by the kENUP Foundation, a Europe-based non-profit supporting research-based innovation in health industries, in January 2021, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic worldwide. The public sector committed 95% of the total spending, or $87.54 billion (€86.5 billion), in just 11 months to the development of vaccinations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccine is driving the growth of the H1N1 vaccine market.

An upsurge in the spread of H1N1 infection is expected to propel the growth of the H1N1 vaccine market going forward. H1N1 influenza refers to a subtype of influenza A virus, a communicable viral illness that causes upper and, in some cases, lower respiratory tract infections in its host. The H1N1 vaccine should be administered as a single 0.5-mL intramuscular injection that helps to prevent infection caused by influenza A (H1N1). Also, helps the body produce its own antibodies against the disease. For instance, according to the Times of India, an India-based daily newspaper, as of August 2022, nearly H1N1 influenza 1,500 cases and 43 deaths have been reported in Maharashtra in the year 2022. Further, according to the Center for Disease Control and Prevention, a US-based government health organization, in October 2021, there were 1,35,046 people tested positive for influenza out of 35,47,791 tests, out of which 1,32,809 were affected by influenza A and 2,237 were affected by influenza B. Therefore, an upsurge in the spread of H1N1 infection is driving the growth of the H1N1 vaccine market.

Strategic collaborations between companies is a key trend that is gaining popularity in the H1N1 (swine flu) vaccination market. Companies in the H1N1 (swine flu) Vaccination market are focusing on strategic collaborations to expand their market share. For instance, in August 2022, A significant, a pharmaceutical company and Open Orphan affiliate hVIVO have agreed to an agreement for $123 million to create a brand-new batch of H1N1 influenza challenge virus. This has stimulated the growth potential of both companies in the industry.

The countries covered in the H1N1 vaccine market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The H1N1 vaccine report is one of a series of new reports from The Business Research Company that provides H1N1 vaccine statistics, including H1N1 vaccine industry global market size, regional shares, competitors with an H1N1 vaccine share, detailed H1N1 vaccine segments, market trends and opportunities, and any further data you may need to thrive in the H1N1 vaccine industry. This H1N1 vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. H1N1 Vaccine Market Characteristics

3. H1N1 Vaccine Market Trends And Strategies

4. H1N1 Vaccine Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On H1N1 Vaccine Market
• 4.2. Ukraine-Russia War Impact On H1N1 Vaccine Market
• 4.3. Impact Of High Inflation On H1N1 Vaccine Market

5. H1N1 Vaccine Market Size And Growth

• 5.1. Global H1N1 Vaccine Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global H1N1 Vaccine Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. H1N1 Vaccine Market Segmentation

• 6.1. Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Inactivated Vaccine
• Live Attenuated Vaccine
• 6.2. Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Intradermal Vaccination
• Intramuscular Vaccination
• Subcutaneous Vaccination
• 6.3. Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Clinics
• Research and Diagnostic Laboratories
• Other End Users

7. H1N1 Vaccine Market Regional And Country Analysis

• 7.1. Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific H1N1 Vaccine Market

• 8.1. Asia-Pacific H1N1 Vaccine Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China H1N1 Vaccine Market

• 9.1. China H1N1 Vaccine Market Overview
• 9.2. China H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India H1N1 Vaccine Market

• 10.1. India H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan H1N1 Vaccine Market

• 11.1. Japan H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia H1N1 Vaccine Market

• 12.1. Australia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia H1N1 Vaccine Market

• 13.1. Indonesia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea H1N1 Vaccine Market

• 14.1. South Korea H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe H1N1 Vaccine Market

• 15.1. Western Europe H1N1 Vaccine Market Overview
• 15.2. Western Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK H1N1 Vaccine Market

• 16.1. UK H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany H1N1 Vaccine Market

• 17.1. Germany H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France H1N1 Vaccine Market

• 18.4. France H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.5. France H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe H1N1 Vaccine Market

• 19.1. Eastern Europe H1N1 Vaccine Market Overview
• 19.2. Eastern Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia H1N1 Vaccine Market

• 20.1. Russia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America H1N1 Vaccine Market

• 21.1. North America H1N1 Vaccine Market Overview
• 21.2. North America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA H1N1 Vaccine Market

• 22.1. USA H1N1 Vaccine Market Overview
• 22.2. USA H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America H1N1 Vaccine Market

• 23.1. South America H1N1 Vaccine Market Overview
• 23.2. South America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil H1N1 Vaccine Market

• 24.1. Brazil H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East H1N1 Vaccine Market

• 25.1. Middle East H1N1 Vaccine Market Overview
• 25.2. Middle East H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa H1N1 Vaccine Market

• 26.1. Africa H1N1 Vaccine Market Overview
• 26.2. Africa H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. H1N1 Vaccine Market Competitive Landscape And Company Profiles

• 27.1. H1N1 Vaccine Market Competitive Landscape
• 27.2. H1N1 Vaccine Market Company Profiles
  • 27.2.1. Sanofi
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Novartis AG
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. GlaxoSmithKline plc
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. CSL Limited
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. AstraZeneca
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The H1N1 Vaccine Market

29. H1N1 Vaccine Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer